ORCA Therapeutics

📍 Nijmegen, Netherlands🗓 Founded 2005👥 6 employees💰 Last funded Apr 2005
Biotechnology🌐 orca-therapeutics.com
Website LinkedIn
ORCA Therapeutics B.V. is a privately-funded biopharmaceutical company designing and developing new oncolytic immunotherapies for treatment of cancer using Oncolytic Replication Competent Agents (ORCA). At ORCA we are passionate about using viruses to cure cancer patients. Our proprietary technologies allow us to engineer powerful oncolytic adenoviruses that selectively kill cancer cells and induce an antitumor immune response. ORCA’s lead compound ORCA-010 is being developed for treatment naive patients with prostate cancer. For more information, please visit http://www.orca-therapeutics.com
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2005
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Netherlands
1
Frequently asked questions
Who invested in ORCA Therapeutics?
ORCA Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did ORCA Therapeutics last raise funding?
The most recent investment in ORCA Therapeutics recorded on gritt.io was in April 2005.
When was ORCA Therapeutics founded?
ORCA Therapeutics was founded in 2005.
What industry is ORCA Therapeutics in?
ORCA Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is ORCA Therapeutics based?
ORCA Therapeutics is headquartered in Nijmegen, Netherlands.